levetiracetam

(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide

A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47581" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47581" NCI Thesaurus)

http://purl.bioontology.org/ontology/PDQ/CDR0000526173

(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide

1-pyrrolidineacetamide, alpha-ethyl-2-oxo-,(S)-

Keppra

102767-28-2

C0377265

C0876060

2006-12-18

A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47581" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47581" NCI Thesaurus)

TRD

C47581

CDR0000526173

Drug/agent

levetiracetam

T109

T121